What does President Trump's Mexican wall plan mean for medical travel across the border? Some Mexican hospital groups have already reported a fall in US patients, but opinion is split on what the long-term effect will be. We talk to operators in the region to find out more.
Archives
Three groups left in race to buy Oberberg
German psychiatric care provider Oberberg Gruppe is close to being sold. Healthcare Europa speaks to a source who says one big private equity group has pulled out of the already, leaving three interested parties.
November 13, 2017
American health group buys minority stake in German hospital – but why?
Sanford Health, a US $4bn+ revenue, not-for-profit healthcare group has just bought a minority stake in privately-held Isar Klinikum, a 240-bed hospital in Munich. We talk to Sanford Health and our contacts in Germany about the deal, two of whom think there is more to it than meets the eye.
November 8, 2017
First “open to all” NHS-funded telehealth primary care app launches
Telehealth provider babylon has launched the first NHS funded telehealth primary care service which is open to all patients, with a 'GP at hand' app that promises NHS tele-consultations within two hours and face-to-face appointments within a day. Now and Evergreen are also working with the NHGS but offer more limited options. We talk to babylon.
November 6, 2017
FREE BLOG Can “Healthcare ATMs” be the primary care panacea India needs?
Indian health insurer Max Bupa Health is launching pioneering technology based around "Healthcare ATMs" which can assess a potential customer's health, and then sell them insurance on the spot. Healthcare Nova speaks to a healthcare operator who already uses these ATMs for health assessment, one who decided not to, and a group that manufactures them - and also looks at how they can be used to sell insurance.
November 2, 2017
NephroPlus plans to expand in India and abroad in 2018
Indian renal care provider NephroPlus is to open 55 more centres across the county by the end of 2018, which will see it operating in 180 locations. Healthcare Nova speaks to CEO Vikram Vuppala about the rollout, centre profitability and imminent international expansion.
November 1, 2017
Medicover targets Indian expansion following Q3 results
Listed pan-European healthcare and medical laboratory services provider Medicover saw its share price dip slightly, by 1.5%, as third quarter results were announced, despite a 16% jump in revenues and a 20% increase in EBITDA. India was announced as a key target for expansion, while Eastern European operations saw particularly strong growth.
October 30, 2017
Buyer found for France’s fifth largest hospital group
Infrastructure private equity group Antin has entered into negotiations to acquire French hospital group Almaviva Sante. We speak to a well-placed investor with knowledge of the deal, and consider why the price we hear being discussed is so low.
October 24, 2017
Aster DM launching an at-home app for patients
UAE and India-based healthcare operator Aster DM is set to launch a network of at-home telehealth services for its patients in Dubai.
October 24, 2017
Turkish hospital giant set for $1bn IPO next year
Medical Park Group, one of Turkey's largest hospital chains, is set to go public in 2018 according to its majority owners. The London Stock Exchange (LSE) has been touted as a candidate for the offering which could value to company at $1bn. Healthcare Europa speaks to a Turkish healthcare consultant about to find out more and to ask if that valuation is realistic.
October 23, 2017
Interview: Pramod Balakrishnan, CEO, Emirates Hospital Group
Healthcare Nova speaks to the CEO of Emirates Hospital Group (EHG), whose company recently signed a deal to have their healthcare facilities managed by NMC. Could a merger-acquisition be on the horizon?
October 17, 2017
Flat revenues lead to share drop for Mediclinic
Mediclinic's shares dropped 4% as its recent struggles were highlighted in a trading statement published Tuesday, October 17, covering the six months to September 30. Revenue was flat - and underlying EBITDA down by 5%.



